Details of the Drug

General Information of Drug (ID: DMMOFX1)

Drug Name
AKCEA-APO(a)-LRX
Indication
Disease Entry ICD 11 Status REF
Hyperlipoproteinemia 5C80 Phase 2 [1]
Cross-matching ID
TTD ID
D0PV0I

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)